ClearanceBrief
Recall Z-1298-2022 ยท JPA System, Multipurpose For In Vitro Coagulation Studies

Haemonetics Corporation

Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping Assay - PlateletMapping ADP & AA (07-014), PlateletMapping ADP (07-015), PlateletMapping AA (07-016). Issue occurs when Platelet Mapping Assay results from a TEG 5000 analyzer are viewed using TEG Manager Software (versions 1.1-4.3.1)

DateApr 19, 2022
StatusTerminated
ReasonWhen the TEG 5000 Analyzer including TEG Analytical Software is used with PlateletMapping (ADP or AA) Assays and TEG Mangement Software, incorrect values of the PlateletMapping ADP or AA % Inhibition and % Aggretagion may be displayed on TEG Manager for the affected assays.
Root causeSoftware design
ActionOn April 22, 2022, the firm notified affected customers of the recall via email. Customers were asked to complete and return the attached acknowledgement form. Upon receipt, Haemonetics will contact the customer to arrange the remote installation of the updated software, version 4.4.0, which will resolve the issue.
Quantity111
DistributionUS Nationwide.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K002177THROMBELASTOGRAPH COAGULATION ANALYZER TEG-5000 SERIES
Haemoscope Corp., Sep 14, 2000
K041502THROMBELASTOGRAPH (TEG) PLATELET MAPPING ASSAY
Haemoscope Corp., Sep 1, 2004